Abstract
Chronic diseases are diseases of long duration and slow progression. Major NCDs (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, rheumatologic diseases and mental health) represent the predominant health problem of the Century. The prevention and control of NCDs are the priority of the World Health Organization 2008 Action Plan, the United Nations 2010 Resolution and the European Union 2010 Council. The novel trend for the management of NCDs is evolving towards integrative, holistic approaches. NCDs are intertwined with ageing. The European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) has prioritised NCDs. To tackle them in their totality in order to reduce their burden and societal impact, it is proposed that NCDs should be considered as a single expression of disease with different risk factors and entities. An innovative integrated health system built around systems medicine and strategic partnerships is proposed to combat NCDs. It includes (i) understanding the social, economic, environmental, genetic determinants, as well as the molecular and cellular mechanisms underlying NCDs; (ii) primary care and practice-based interprofessional collaboration; (iii) carefully phenotyped patients; (iv) development of unbiased and accurate biomarkers for comorbidities, severity and follow up of patients; (v) socio-economic science; (vi) development of guidelines; (vii) training; and (viii) policy decisions. The results could be applicable to all countries and adapted to local needs, economy and health systems. This paper reviews the complexity of NCDs intertwined with ageing. It gives an overview of the problem and proposes two practical examples of systems medicine (MeDALL) applied to allergy and to NCD co-morbidities (MACVIA-LR, Reference Site of the European Innovation Partnership on Active and Healthy Ageing).
Keywords: Chronic disease, co-morbidities, health system, systems medicine, patient, active and healthy ageing, MeDALL, MACVIA-LR.
Current Pharmaceutical Design
Title:Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing. From Concept to Implementation and Policies
Volume: 20 Issue: 38
Author(s): Ariane Sultan, George Crooks, Alexander Chuchalin, Niels H. Chavannes, Anne Cambon-Thomsen, Cristina Barbara, Rudi Balling, Charles Auffray, Anne Wojtusciszyn, Antoni Dedeu, Francois Roubille, Michel Rodier, Jean-Marie Robine, Francoise Radier-Pontal, Marie-Christine Picot, Jacques Pelissier, Gregory Ninot, Jacques Morel, Leonardo M. Fabbri, Judith Garcia-Aymerich, Jawad Hajjam, Elisabete Melo Gomes, Susana Palkonen, Francois Piette, Christophe Pison, David Price, Boleslaw Samolinski, Holger J. Schunemann, Peter J. Sterk, Panayiotis Yiallouros, Josep Roca, Philippe Van de Perre, Jacques Mercier, Frederic Abecassis, William Camu, Jacques Bringer, Arnaud Bourdin, Hubert Blain, Anna Bedbrook, Melanie Badin, Antoine Avignon, Pierre Aubas, Guilhaume Cayla, Josep M. Anto, Nicolas Best, Rodolphe Bourret, Thierry Camuzat, Alfredo Cesario, Michel Dauzat, Christian Jorgensen, Jean Bousquet, David J. Costa, Philippe Courtet, Jean-Paul Cristol, Pascal Demoly, Jean-Emmanuel de la Coussaye, Pierre Fesler, Fares Gouzi, Jean-Christophe Gris, Bernard Guillot, Maurice Hayot, Claude Jeandel, Olivier Jonquet, Laurent Journot, Sylvain Lehmann and Gwenaelle Mathieu
Affiliation:
Keywords: Chronic disease, co-morbidities, health system, systems medicine, patient, active and healthy ageing, MeDALL, MACVIA-LR.
Abstract: Chronic diseases are diseases of long duration and slow progression. Major NCDs (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, rheumatologic diseases and mental health) represent the predominant health problem of the Century. The prevention and control of NCDs are the priority of the World Health Organization 2008 Action Plan, the United Nations 2010 Resolution and the European Union 2010 Council. The novel trend for the management of NCDs is evolving towards integrative, holistic approaches. NCDs are intertwined with ageing. The European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) has prioritised NCDs. To tackle them in their totality in order to reduce their burden and societal impact, it is proposed that NCDs should be considered as a single expression of disease with different risk factors and entities. An innovative integrated health system built around systems medicine and strategic partnerships is proposed to combat NCDs. It includes (i) understanding the social, economic, environmental, genetic determinants, as well as the molecular and cellular mechanisms underlying NCDs; (ii) primary care and practice-based interprofessional collaboration; (iii) carefully phenotyped patients; (iv) development of unbiased and accurate biomarkers for comorbidities, severity and follow up of patients; (v) socio-economic science; (vi) development of guidelines; (vii) training; and (viii) policy decisions. The results could be applicable to all countries and adapted to local needs, economy and health systems. This paper reviews the complexity of NCDs intertwined with ageing. It gives an overview of the problem and proposes two practical examples of systems medicine (MeDALL) applied to allergy and to NCD co-morbidities (MACVIA-LR, Reference Site of the European Innovation Partnership on Active and Healthy Ageing).
Export Options
About this article
Cite this article as:
Sultan Ariane, Crooks George, Chuchalin Alexander, Chavannes H. Niels, Cambon-Thomsen Anne, Barbara Cristina, Balling Rudi, Auffray Charles, Wojtusciszyn Anne, Dedeu Antoni, Roubille Francois, Rodier Michel, Robine Jean-Marie, Radier-Pontal Francoise, Picot Marie-Christine, Pelissier Jacques, Ninot Gregory, Morel Jacques, Fabbri M. Leonardo, Garcia-Aymerich Judith, Hajjam Jawad, Gomes Melo Elisabete, Palkonen Susana, Piette Francois, Pison Christophe, Price David, Samolinski Boleslaw, Schunemann J. Holger, Sterk J. Peter, Yiallouros Panayiotis, Roca Josep, Perre Van de Philippe, Mercier Jacques, Abecassis Frederic, Camu William, Bringer Jacques, Bourdin Arnaud, Blain Hubert, Bedbrook Anna, Badin Melanie, Avignon Antoine, Aubas Pierre, Cayla Guilhaume, Anto M. Josep, Best Nicolas, Bourret Rodolphe, Camuzat Thierry, Cesario Alfredo, Dauzat Michel, Jorgensen Christian, Bousquet Jean, Costa J. David, Courtet Philippe, Cristol Jean-Paul, Demoly Pascal, Coussaye de la Jean-Emmanuel, Fesler Pierre, Gouzi Fares, Gris Jean-Christophe, Guillot Bernard, Hayot Maurice, Jeandel Claude, Jonquet Olivier, Journot Laurent, Lehmann Sylvain and Mathieu Gwenaelle, Systems Medicine Approaches for the Definition of Complex Phenotypes in Chronic Diseases and Ageing. From Concept to Implementation and Policies, Current Pharmaceutical Design 2014; 20(38) . https://dx.doi.org/10.2174/1381612820666140314115505
| DOI https://dx.doi.org/10.2174/1381612820666140314115505 |
Print ISSN 1381-6128 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Allegations from Whistleblowers
- Publishing Ethics
- Increase Visibility Of Your Article
- Self Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
A Review of Voltammetric Methods for Determination of Dopamine Agonists
Current Analytical Chemistry Prognostic Significance of Asymptomatic Myocardial Ischemia in Women vs. Men
Current Pharmaceutical Design Molecular Effects Elicited In Vitro by Red Wine on Human Healthy Peripheral Blood Mononuclear Cells: Potential Therapeutical Application of Polyphenols to Diet-Related Chronic Diseases
Current Pharmaceutical Design Genomic Variations Affecting Biological Effects of Statins
Current Drug Metabolism Flavonoids in Human Health: From Structure to Biological Activity
Current Nutrition & Food Science Bio-Antioxidants – A Chemical Base of Their Antioxidant Activity and Beneficial Effect on Human Health
Current Medicinal Chemistry Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer’s Disease: A Meta-Analysis
Current Alzheimer Research Angiotensin-Converting Enzyme Inhibitors in Veterinary Medicine
Current Pharmaceutical Design Novel Antiinflammatory and Antiinfective Agents
Anti-Infective Agents in Medicinal Chemistry Developing the Evidence Base for Cancer Chemoprevention: Use of Meta-Analysis
Current Drug Targets Roles of IL-6-gp130 Signaling in Vascular Inflammation
Current Cardiology Reviews Skeletal Myoblasts for Heart Regeneration and Repair: State of the Art and Perspectives on the Mechanisms for Functional Cardiac Benefits
Current Pharmaceutical Design Platelet in Progression of Atherosclerosis: A Potential Target in Diabetic Patients
Current Diabetes Reviews Experimental Benefits of Sex Hormones on Vascular Function and the Outcome of Hormone Therapy in Cardiovascular Disease
Current Cardiology Reviews Edaravone (3-Methyl-1-Phenyl-2-Pyrazolin-5-one), A Novel Free Radical Scavenger, for Treatment of Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Effects of Dietary Intake and Supplementation of Fatty Acids on Cardiometabolic Disorders in Humans: a Lesson from a Large Number of Meta-Analyses
Letters in Drug Design & Discovery Nocturnal Blood Pressure Abnormalities in Obstructive Sleep Apnea - Clinical Predictors
Current Respiratory Medicine Reviews Herbal and Traditional Chinese Medicine for the Treatment of Cardiovascular Complications in Diabetes Mellitus
Current Diabetes Reviews Use of Chronic Disease Registries to Optimize Cardiovascular Health
Current Vascular Pharmacology Recent Patents in Diagnosis and Treatment for Inborn Errors of Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery




